Meeting Logistics
All working group Teleconference Information, Web Session Details, and Meeting Schedules
Active Action Items
Owner(s) | Action Item | Due Date | Status |
---|---|---|---|
Group Members | Find any disease elements that are not already represented | Ongoing | Ongoing |
Mary Cooper / Susan Pannoni | Look into CDISC to see their responses and match what is in our spreadsheet | Jul 10 | Open |
Susan Pannoni | Add column for comments/thoughts to new CDE tab(s) to note reasons for not using elements | Jul 10 | Open |
Liz Ness | Pull up example for when immunological response could be used | Jul 10 | Open |
Susan Pannoni | Research immunological response - FDA considers this under biologic agents | Jul 10 | Open |
Liz Ness | Tumor pathologic response - Uncover form and possible value list. Lymphoma SME? | Jul 10 | Open |
Diane Paul | Send some examples of QOL performance status | Jul 10 | In-Process |
Working Group | Review list of values for current response by disease distributed by Eleanor Leung-Hollins | Jul 10 | Open |
Susan Pannoni | Follow up with outstanding action items list to see if anything still to be done | Jul 10 | Open |
Working Group | Review the new CDE Spreadsheet for the next meeting (ensure it covers the correct definitions and terms are correct) | Jul 15 | Open |
Working Group Documents
- NCI Leukemia Response Status (Updated July 1)
- Round 5 Response-Procedure Results Document - with CDEs (Last Updated June 26)
- COH1024V03
- COH1059
- COH2004
- COH2077
- COH2331
- COH2649
- CRFWG_roadmap slide
- Solid tumor evaluation form_GOG